Healthy Volunteers clinical trials

Explore recruiting healthy volunteers clinical trials.

Recruiting healthy volunteers studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Volunteers trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NT-0796 in Healthy Volunteers and Patients with Parkinson’s Disease.

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2 Proof-of-Concept clinical trial to quantify myocardial manganese uptake rate by cardiovascular magnetic resonance imaging following mangafodipir trisodium administration in healthy volunteers and heart failure patients with preserved ejection fraction caused by hypertrophic cardiomyopathy or cardiac amyloidosis.

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Rivaroxaban sotorasib interaction study (the ROSIE-study)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Reward-specific changes of cerebral dopamine synthesis in healthy volunteers and depressed patients

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, Open-label, Single-Dose, Two-treatment, Two-period, Cross-over, Pivotal Bioequivalence Study Comparing Amoxicilin/Clavulanic acid powder for oral suspension 600 mg/42.9 mg/5 mL to Augmentin ES 600 mg/42.9 mg/5 mL powder for oral suspension in Healthy Adult Male and Female Volunteers under Fed Conditions.

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril capsule, hard 10mg/5mg/5mg versus reference products Crestor 10 mg film coated tablets, Norvasc 5 mg tablets, Tritace 5 mg tablets in healthy male and female subjects under fasting conditions. Sponsor’s Study Number: ROS-AML-RAM-BIO-02-23

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Healthy Volunteers trials by city

Healthy Volunteers in Toronto Healthy Volunteers in Vancouver Healthy Volunteers in Montreal Healthy Volunteers in Calgary Healthy Volunteers in Edmonton Healthy Volunteers in Ottawa Healthy Volunteers in Winnipeg Healthy Volunteers in Quebec City Healthy Volunteers in Hamilton Healthy Volunteers in Kitchener Healthy Volunteers in London Healthy Volunteers in Halifax Healthy Volunteers in New York Healthy Volunteers in Los Angeles Healthy Volunteers in Chicago Healthy Volunteers in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease